Lee W. Jones, PhD, has been appointed as the first Scientific Director of the Duke Center for Cancer Survivorship (DCCS). Jones is an Associate Professor in the Department of Radiation Oncology.

Duke University Medical Center and National Cancer Institute scientists have discovered that a novel genetic alteration – a second copy of an entire gene – is a cause of familial chordoma, an uncommon form of cancer arising in bones and frequently affecting the nervous system.

Two Duke Comprehensive Cancer Center scientists have won prestigious National Institutes of Health Director's awards to pursue novel research. Tannishtha Reya, PhD, an associate professor of pharmacology and cancer biology, has won an NIH Director's Pioneer Award and Michel Bagnat, PhD, assistant professor of cell biology, won an NIH Director's New Innovator Award.

A moderate amount of exercise most days of the week may contribute to a lower risk of prostate cancer, and lower grade tumors among those men who are diagnosed with the disease following biopsy, say researchers at Duke University Medical Center and the Durham Veterans Affairs Hospital.

Duke University Health System (DUHS) announced it is moving forward with the construction of a dedicated, state-of-the-art Cancer Center and the new Duke Medicine Pavilion, a major expansion of surgery and critical care services at Duke University Hospital (DUH).